Stocks and Investing
Stocks and Investing
Mon, October 17, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sat, October 15, 2022
[ 12:00 AM ] - United States, WOPRAI
Fri, October 14, 2022
[ 12:00 AM ] - United States, WOPRAI
Vikram Purohit Maintained (AXSM) at Hold with Increased Target to $74 on, Oct 14th, 2022
Vikram Purohit of Morgan Stanley, Maintained "Axsome Therapeutics, Inc." (AXSM) at Hold with Increased Target from $71 to $74 on, Oct 14th, 2022.
Vikram has made no other calls on AXSM in the last 4 months.
There are 6 other peers that have a rating on AXSM. Out of the 6 peers that are also analyzing AXSM, 0 agree with Vikram's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with Vikram
- Chris Howerton of "Jefferies" Maintained at Strong Buy with Decreased Target to $90 on, Friday, September 30th, 2022
- Graig Suvannavejh of "Mizuho" Initiated at Strong Buy and Held Target at $76 on, Wednesday, September 7th, 2022
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $210 on, Tuesday, August 23rd, 2022
- Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $75 on, Monday, August 22nd, 2022
- Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $64 on, Wednesday, June 29th, 2022
- Joseph Thome of "Cowen & Co." Maintained at Buy with Increased Target to $130 on, Wednesday, June 29th, 2022
Contributing Sources